Related Experiment Video
Updated: Mar 2, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
RIZ1 is regulated by estrogen and suppresses tumor progression in endometrial cancer
Tingting Yang1, Chune Ren1, Aifang Jiang1
1Center for Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, China.
Abstract:
Endometrial cancer (EC) is the estrogen-dependent gynecologic malignancy, however the molecular mechanism involved in the development and progression of EC remain unclear. The aim of this study was to investigate the role of RIZ1 in EC. Immunohistochemical analysis revealed that RIZ1was decreased in EC than in normal endometrium. Lower RIZ1 level was correlated with high-grade carcinoma (p = 0.048) and positive expression of ERα (p = 0.004). In EC cells, estrogen could down regulated the expression of RIZ1, however, ICI182,780 could up regulated the expression of RIZ1. Besides, in vitro and in vivo, RIZ1 could remarkably suppress tumor proliferation, metastasis and invasion. Our data support that RIZ1 was a novel tumor suppressor and could provide a potential therapeutic target in human EC.
Insights
RIZ1 is decreased in endometrial cancer (EC), a gynecologic malignancy. This study shows RIZ1 suppresses tumor growth and metastasis, indicating its potential as a therapeutic target for EC.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cancer Research
Background:
- Endometrial cancer (EC) is an estrogen-dependent malignancy.
- The molecular mechanisms driving EC development and progression are not fully understood.
Purpose of the Study:
- To investigate the role of RIZ1 in endometrial cancer.
- To determine if RIZ1 acts as a tumor suppressor in EC.
Main Methods:
- Immunohistochemical analysis of RIZ1 expression in EC tissues.
- In vitro and in vivo experiments to assess RIZ1's effect on tumor cells.
- Analysis of RIZ1 expression in response to estrogen and ICI 182,780.
Main Results:
- RIZ1 expression was significantly decreased in EC tissues compared to normal endometrium.
- Lower RIZ1 levels correlated with high-grade EC and positive ERα expression.
- Estrogen downregulated RIZ1, while ICI 182,780 upregulated it in EC cells.
- RIZ1 suppressed tumor proliferation, metastasis, and invasion in vitro and in vivo.
Conclusions:
- RIZ1 functions as a novel tumor suppressor in endometrial cancer.
- RIZ1 represents a potential therapeutic target for human EC.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

